Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D03RFS
|
||||
| Former ID |
DNC009562
|
||||
| Drug Name |
N-(3,3-Diphenyl)propyl-2-phenylacetamide
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [529563] | ||
| Formula |
C23H23NO
|
||||
| Canonical SMILES |
C1=CC=C(C=C1)CC(=O)NCCC(C2=CC=CC=C2)C3=CC=CC=C3
|
||||
| InChI |
1S/C23H23NO/c25-23(18-19-10-4-1-5-11-19)24-17-16-22(20-12-6-2-7-13-20)21-14-8-3-9-15-21/h1-15,22H,16-18H2,(H,24,25)
|
||||
| InChIKey |
JFOKDVSVRVUJTI-UHFFFAOYSA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Cannabinoid receptor 1 | Target Info | Inhibitor | [529563] | |
| PANTHER Pathway | Endogenous cannabinoid signaling | ||||
| Pathway Interaction Database | N-cadherin signaling events | ||||
| References | |||||